A world-leading biopharmaceutical company sought to expand its neonatology portfolio through strategic partnerships and early-stage technology adoption. Our strategic intelligence enabled the client to prioritize their partnership opportunities and confidently expand their portfolio.
Client Background:
A global, research-driven biopharmaceutical organization with a strong focus on innovation in respiratory health, rare diseases, and specialty care was looking to expand its neonatology portfolio.
Engagement Objective:
A structured innovation scouting and competitive assessment program was conducted to support informed decision-making: Our team:
- Performed global technology scouting to identify early-stage (TRL 3–6) solutions across neonatal prevention, diagnosis, therapy, and disease management through secondary research
- Conducted in-depth technical analysis of shortlisted solutions, covering development stage, therapeutic indication, target pathways, modality, delivery formats, mechanism of action, and clinical rationale
- Evaluated the implementability and scalability of solutions suitable for low-income country settings
- Benchmarked identified technologies across multiple parameters, including safety profile, scientific validation, ease of use, prototype readiness, and scalability potential
- Generated actionable technical and strategic insights, profiling key technologies and innovators across each neonatal indication
Client Impact:
- Strategic Innovation Visibility – Provided the client with a comprehensive view of emerging early-stage technologies addressing major neonatal disorders, enabling structured innovation prioritization.
- Partner Identification & Shortlisting – Enabled identification of high-potential innovators and early-stage companies suitable for future collaboration, co-development, or strategic partnerships.
- Risk-Adjusted Technology Selection – Supported informed evaluation of technical maturity, feasibility, and differentiation of solutions at early TRL stages.
- Competitive Intelligence Enablement – Delivered benchmarking and competitive insights that clarified positioning of emerging solutions relative to existing and pipeline approaches.
- Sustainable & Global Health Alignment – Identified neonatal solutions that were implementable in low-income countries, supporting the client’s global health and access objectives.
- Accelerated External Innovation Strategy – Equipped the client with decision-ready insights to advance selected technologies into structured engagement, validation, or pilot programs.
Outcome Snapshot:
